$ARDX
Ardelyx Inc

2020 Q4 Form 10-Q Financial Statement

#000155837020012720 Filed on November 05, 2020

View on sec.gov

Income Statement

Concept 2020 Q4 2020 Q3 2019 Q3
Revenue $1.809M $2.713M $3.013M
YoY Change -19.6% -9.96% 1672.35%
Cost Of Revenue $0.00 $0.00 $600.0K
YoY Change -100.0%
Gross Profit $1.810M $2.713M $2.413M
YoY Change -19.56% 12.43% 1319.41%
Gross Profit Margin 100.06% 100.0% 80.09%
Selling, General & Admin $11.34M $7.630M $6.920M
YoY Change 65.31% 10.26% 16.11%
% of Gross Profit 626.52% 281.24% 286.78%
Research & Development $18.11M $12.24M $17.58M
YoY Change 27.18% -30.38% -2.01%
% of Gross Profit 1000.55% 451.16% 728.55%
Depreciation & Amortization $420.0K $440.0K $640.0K
YoY Change -17.65% -31.25% -4.48%
% of Gross Profit 23.2% 16.22% 26.52%
Operating Expenses $29.45M $12.24M $17.58M
YoY Change 39.57% -30.38% -26.44%
Operating Profit -$27.64M -$17.16M -$22.09M
YoY Change 46.63% -22.31% -6.92%
Interest Expense -$1.310M $1.202M $1.443M
YoY Change -6.43% -16.7%
% of Operating Profit
Other Income/Expense, Net $80.00K $255.0K $294.0K
YoY Change -82.61% -13.27% -175.38%
Pretax Income -$28.87M -$18.11M -$23.24M
YoY Change 45.88% -22.08% -3.7%
Income Tax $0.00 $0.00 $301.0K
% Of Pretax Income
Net Earnings -$28.88M -$18.11M -$23.54M
YoY Change 45.91% -23.07% -2.45%
Net Earnings / Revenue -1596.24% -667.45% -781.25%
Basic Earnings Per Share -$0.20
Diluted Earnings Per Share -$317.4K -$0.20 -$374.7K
COMMON SHARES
Basic Shares Outstanding 90.25M 89.37M shares
Diluted Shares Outstanding 89.37M shares

Balance Sheet

Concept 2020 Q4 2020 Q3 2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $186.5M $185.5M $103.5M
YoY Change -24.66% 79.22% -44.47%
Cash & Equivalents $91.03M $91.01M $92.67M
Short-Term Investments $95.45M $94.49M $10.90M
Other Short-Term Assets $8.200M $7.500M $4.600M
YoY Change 115.79% 63.04% -40.26%
Inventory
Prepaid Expenses
Receivables $0.00 $800.0K $2.700M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $194.7M $193.8M $110.8M
YoY Change -22.76% 74.9% -44.41%
LONG-TERM ASSETS
Property, Plant & Equipment $1.936M $2.111M $8.400M
YoY Change -43.66% -74.87% 40.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $2.100M
YoY Change
Other Assets $552.0K $249.0K $200.0K
YoY Change 75.8% 24.5% -85.71%
Total Long-Term Assets $6.876M $4.762M $8.600M
YoY Change -10.93% -44.63% 16.22%
TOTAL ASSETS
Total Short-Term Assets $194.7M $193.8M $110.8M
Total Long-Term Assets $6.876M $4.762M $8.600M
Total Assets $201.6M $198.6M $119.4M
YoY Change -22.41% 66.29% -42.24%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.626M $2.490M $2.700M
YoY Change 157.25% -7.78% 17.39%
Accrued Expenses $12.80M $13.20M $14.00M
YoY Change 1.59% -5.71% 30.84%
Deferred Revenue $4.177M
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $4.200M $0.00
YoY Change 250.0%
Total Short-Term Liabilities $28.42M $16.53M $17.70M
YoY Change 27.88% -6.59% 14.19%
LONG-TERM LIABILITIES
Long-Term Debt $46.60M $50.70M $49.80M
YoY Change -4.51% 1.81% 1.63%
Other Long-Term Liabilities $400.0K $0.00 $2.800M
YoY Change -80.95% -100.0% 300.0%
Total Long-Term Liabilities $47.00M $50.70M $52.60M
YoY Change -7.66% -3.61% 5.84%
TOTAL LIABILITIES
Total Short-Term Liabilities $28.42M $16.53M $17.70M
Total Long-Term Liabilities $47.00M $50.70M $52.60M
Total Liabilities $75.45M $67.22M $70.30M
YoY Change 3.18% -4.39% 7.82%
SHAREHOLDERS EQUITY
Retained Earnings -$554.8M -$525.9M
YoY Change 20.48%
Common Stock $680.9M $657.1M
YoY Change 5.22%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $126.1M $131.3M $49.16M
YoY Change
Total Liabilities & Shareholders Equity $201.6M $198.6M $119.4M
YoY Change -22.41% 66.29% -42.24%

Cashflow Statement

Concept 2020 Q4 2020 Q3 2019 Q3
OPERATING ACTIVITIES
Net Income -$28.88M -$18.11M -$23.54M
YoY Change 45.91% -23.07% -2.45%
Depreciation, Depletion And Amortization $420.0K $440.0K $640.0K
YoY Change -17.65% -31.25% -4.48%
Cash From Operating Activities -$17.59M -$19.88M -$20.62M
YoY Change 58.04% -3.59% -23.69%
INVESTING ACTIVITIES
Capital Expenditures -$250.0K -$40.00K -$120.0K
YoY Change -66.67% -400.0%
Acquisitions
YoY Change
Other Investing Activities -$3.320M $9.640M $23.56M
YoY Change -94.01% -59.08% 134.19%
Cash From Investing Activities -$3.570M $9.600M $23.44M
YoY Change -93.56% -59.04% 132.08%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 21.19M 790.0K 210.0K
YoY Change -86.33% 276.19% 10.53%
NET CHANGE
Cash From Operating Activities -17.59M -19.88M -20.62M
Cash From Investing Activities -3.570M 9.600M 23.44M
Cash From Financing Activities 21.19M 790.0K 210.0K
Net Change In Cash 30.00K -9.490M 3.030M
YoY Change -99.97% -413.2% -118.11%
FREE CASH FLOW
Cash From Operating Activities -$17.59M -$19.88M -$20.62M
Capital Expenditures -$250.0K -$40.00K -$120.0K
Free Cash Flow -$17.34M -$19.84M -$20.50M
YoY Change 55.8% -3.22% -24.24%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
88817741
dei Entity Central Index Key
EntityCentralIndexKey
0001437402
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Entity Address Address Line1
EntityAddressAddressLine1
34175 Ardenwood Boulevard
dei Entity Address City Or Town
EntityAddressCityOrTown
Fremont
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Entity Shell Company
EntityShellCompany
false
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
90243409
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3436000
dei Document Period End Date
DocumentPeriodEndDate
2020-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-36485
dei Entity Registrant Name
EntityRegistrantName
ARDELYX, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-1303944
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2402000
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94555
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
9000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3970000
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
249000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
314000
dei City Area Code
CityAreaCode
510
dei Local Phone Number
LocalPhoneNumber
745-1700
dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001
dei Trading Symbol
TradingSymbol
ARDX
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
CY2020Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
90248465
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
91009000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
181133000
CY2020Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
94488000
CY2019Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
66379000
CY2020Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
750000
CY2019Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
750000
CY2020Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7546000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3800000
CY2020Q3 us-gaap Assets Current
AssetsCurrent
193793000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
252062000
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2111000
CY2020Q3 us-gaap Assets
Assets
198555000
CY2019Q4 us-gaap Assets
Assets
259782000
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2490000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2187000
CY2020Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3722000
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4453000
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2770000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2608000
CY2019Q4 us-gaap Loans Payable Current
LoansPayableCurrent
1183000
CY2020Q3 us-gaap Deferred Revenue
DeferredRevenue
885000
CY2019Q4 us-gaap Deferred Revenue
DeferredRevenue
4541000
CY2020Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
6667000
CY2019Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
7248000
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
16534000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
22220000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2076000
CY2020Q3 us-gaap Long Term Loans Payable
LongTermLoansPayable
50681000
CY2019Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
48831000
CY2020Q3 us-gaap Liabilities
Liabilities
67215000
CY2019Q4 us-gaap Liabilities
Liabilities
73127000
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
9000
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2020Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17410000
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
90243409
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
88817741
CY2020Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
657130000
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
647078000
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-525889000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-460452000
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
90000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
20000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
131340000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
186655000
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
198555000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
259782000
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2713000
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3013000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5762000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3031000
CY2019Q3 us-gaap Cost Of Revenue
CostOfRevenue
600000
us-gaap Cost Of Revenue
CostOfRevenue
141000
us-gaap Cost Of Revenue
CostOfRevenue
600000
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12240000
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
17580000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
46948000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
57436000
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7634000
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6922000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
21810000
CY2020Q3 us-gaap Costs And Expenses
CostsAndExpenses
19874000
CY2019Q3 us-gaap Costs And Expenses
CostsAndExpenses
25102000
us-gaap Costs And Expenses
CostsAndExpenses
68899000
us-gaap Costs And Expenses
CostsAndExpenses
75446000
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-17161000
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-22089000
us-gaap Operating Income Loss
OperatingIncomeLoss
-63137000
us-gaap Operating Income Loss
OperatingIncomeLoss
-72415000
CY2020Q3 us-gaap Interest Expense
InterestExpense
1202000
CY2019Q3 us-gaap Interest Expense
InterestExpense
1443000
us-gaap Interest Expense
InterestExpense
3785000
us-gaap Interest Expense
InterestExpense
4328000
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
255000
CY2019Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
294000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1485000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1896000
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-18108000
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-23238000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-65437000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-74847000
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
301000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
303000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-18108000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-23539000
us-gaap Net Income Loss
NetIncomeLoss
-65437000
us-gaap Net Income Loss
NetIncomeLoss
-75150000
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.20
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.37
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.73
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.20
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
89365798
CY2019Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
62828513
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
89109772
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
62676591
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-18108000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-23539000
us-gaap Net Income Loss
NetIncomeLoss
-65437000
us-gaap Net Income Loss
NetIncomeLoss
-75150000
CY2020Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-227000
CY2019Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-12000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
70000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
42000
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-18335000
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-23551000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-65367000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-75108000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
146350000
CY2020Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
459000
CY2020Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
339000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2527000
CY2020Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-227000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-18108000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
131340000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
186655000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
834000
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
310000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
759000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8149000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
70000
us-gaap Net Income Loss
NetIncomeLoss
-65437000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
131340000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
68617000
CY2019Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
200000
CY2019Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
13000
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3879000
CY2019Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-12000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-23539000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
49158000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
115813000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
397000
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
311000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
21000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7724000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
81000
ardx Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-1914000
us-gaap Share Based Compensation
ShareBasedCompensation
7724000
us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
290000
us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
246000
ardx Noncash Interest Expense
NoncashInterestExpense
393000
ardx Noncash Interest Expense
NoncashInterestExpense
353000
ardx Increase Decrease In Unbilled Revenue
IncreaseDecreaseInUnbilledRevenue
-5000000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3748000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3068000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
303000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
541000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-731000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
42000
us-gaap Net Income Loss
NetIncomeLoss
-75150000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
49158000
us-gaap Profit Loss
ProfitLoss
-65437000
us-gaap Profit Loss
ProfitLoss
-75150000
us-gaap Depreciation
Depreciation
1399000
us-gaap Depreciation
Depreciation
1993000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
416000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
550000
us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
235000
us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
231000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
241000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
666000
ardx Non Cash Lease Expense
NonCashLeaseExpense
1568000
ardx Non Cash Lease Expense
NonCashLeaseExpense
1356000
us-gaap Share Based Compensation
ShareBasedCompensation
8149000
ardx Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-1301000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-871000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-3237000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-3656000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-63845000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-65347000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
79402000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
115484000
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
107200000
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
36325000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
74000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
325000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-27872000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
78834000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
1593000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
418000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1593000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
418000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-90124000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
13905000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
181133000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
78768000
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
91009000
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
92673000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
5810000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2020Q3 ardx Cash Cash Equivalents And Short Term Investments Fair Value Disclosure
CashCashEquivalentsAndShortTermInvestmentsFairValueDisclosure
185500000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and judgments that affect the amounts reported in the financial statements and accompanying notes thereto. On an ongoing basis, management evaluates its estimates, including those related to recognition of revenue, clinical trial accruals, contract manufacturing accruals, the fair value of assets and liabilities, income taxes and stock-based compensation. Management bases its estimates on historical experience and on various other market-specific and relevant assumptions that management believes to be reasonable under the circumstances. Actual results could materially differ from those estimates.</p>
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
91009000
CY2020Q3 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
91009000
CY2020Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
94398000
CY2020Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
94000
CY2020Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
4000
CY2020Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
94488000
CY2020Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
185407000
CY2020Q3 ardx Cash Cash Equivalents And Short Term Investments Gross Unrealized Gains
CashCashEquivalentsAndShortTermInvestmentsGrossUnrealizedGains
94000
CY2020Q3 ardx Cash Cash Equivalents And Short Term Investments Gross Unrealized Losses
CashCashEquivalentsAndShortTermInvestmentsGrossUnrealizedLosses
4000
CY2020Q3 ardx Cash Cash Equivalents And Short Term Investments Fair Value Disclosure
CashCashEquivalentsAndShortTermInvestmentsFairValueDisclosure
185497000
CY2019Q4 us-gaap Other Cash Equivalents At Carrying Value
OtherCashEquivalentsAtCarryingValue
181130000
CY2019Q4 ardx Cash And Cash Equivalents Gross Unrealized Gains
CashAndCashEquivalentsGrossUnrealizedGains
3000
CY2019Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
181133000
CY2019Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
66362000
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
20000
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
3000
CY2019Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
66379000
CY2019Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
247492000
CY2020Q3 ardx Debt Instrument Unaccreted Value Final Fee
DebtInstrumentUnaccretedValueFinalFee
827000
CY2020Q3 us-gaap Long Term Debt
LongTermDebt
50681000
CY2020Q3 us-gaap Long Term Loans Payable
LongTermLoansPayable
50681000
CY2019Q4 ardx Cash Cash Equivalents And Short Term Investments Gross Unrealized Gains
CashCashEquivalentsAndShortTermInvestmentsGrossUnrealizedGains
23000
CY2019Q4 ardx Cash Cash Equivalents And Short Term Investments Gross Unrealized Losses
CashCashEquivalentsAndShortTermInvestmentsGrossUnrealizedLosses
3000
CY2019Q4 ardx Cash Cash Equivalents And Short Term Investments Fair Value Disclosure
CashCashEquivalentsAndShortTermInvestmentsFairValueDisclosure
247512000
us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale
0
CY2019 us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale
0
CY2020Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
0
CY2018Q2 us-gaap Business Exit Costs1
BusinessExitCosts1
1500000
CY2019Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
969000
CY2018Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
533000
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
290000
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
246000
CY2020Q3 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
1259000
CY2019Q3 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
779000
CY2018Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
50000000.0
CY2018Q2 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.0745
CY2018Q2 ardx Percentage Of Premium Payable On Redemption Of Term Loan
PercentageOfPremiumPayableOnRedemptionOfTermLoan
0.01
CY2018Q2 ardx Fee Payable Upon Closing Of Term Loan
FeePayableUponClosingOfTermLoan
500000
CY2018Q2 ardx Default Interest Rate
DefaultInterestRate
0.040
CY2020Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
51975000
CY2020Q3 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
467000
us-gaap Net Income Loss
NetIncomeLoss
-75150000
us-gaap Operating Lease Cost
OperatingLeaseCost
1944000
CY2020Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
767000
CY2019Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
660000
us-gaap Operating Lease Payments
OperatingLeasePayments
2288000
CY2020Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y
CY2020Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.1299
us-gaap Operating Lease Cost
OperatingLeaseCost
1944000
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.37
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2402000
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2770000
CY2020Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
2770000
CY2020Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
648000
CY2019Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
648000
us-gaap Operating Lease Payments
OperatingLeasePayments
1890000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
777000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2183000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2960000
CY2020Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
190000
CY2020Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
2770000
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2770000
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.09
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.03
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
89365798
CY2019Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
62828513
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
89109772
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
62676591
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.20
CY2019Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3879000
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2527000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8149000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7724000
CY2015Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
2172899
CY2015Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.125
CY2015Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
13.91
CY2015Q2 ardx Warrant Term
WarrantTerm
P5Y
ardx Warrants Exercised In Period
WarrantsExercisedInPeriod
0
CY2020Q3 ardx Maximum Aggregate Offering Price
MaximumAggregateOfferingPrice
250000000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-18108000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-23539000
us-gaap Net Income Loss
NetIncomeLoss
-65437000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.73
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.20
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9600000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10400000
CY2019Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10500000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10200000
CY2019Q3 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0
CY2020Q3 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0

Files In Submission

Name View Source Status
0001558370-20-012720-index-headers.html Edgar Link pending
0001558370-20-012720-index.html Edgar Link pending
0001558370-20-012720.txt Edgar Link pending
0001558370-20-012720-xbrl.zip Edgar Link pending
ardx-20200930.xsd Edgar Link pending
ardx-20200930x10q.htm Edgar Link pending
ardx-20200930x10q_htm.xml Edgar Link completed
ardx-20200930xex31d1.htm Edgar Link pending
ardx-20200930xex31d2.htm Edgar Link pending
ardx-20200930xex32d1.htm Edgar Link pending
ardx-20200930_cal.xml Edgar Link unprocessable
ardx-20200930_def.xml Edgar Link unprocessable
ardx-20200930_lab.xml Edgar Link unprocessable
ardx-20200930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending